Clinical Trial Update: To Study the Efficacy and Safety of Renessans in Chronic HCV Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Renessans for chronic hepatitis C is reported, sponsored by MTI Medical Private Limited (Pakistan); current status is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Rennessans

Snippet

Sponsor: MTI Medical Private Limited, Pakistan | Conditions: Hepatitis C, Chronic | Phase 3 | Status: UNKNOWN